Clinical Trials on Opiates in Russian Federation

Total 3 results

Alkermes, Inc.

Completed

ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence

Opiate Dependence

Russian Federation
Yale University
National Institute on Drug Abuse (NIDA); St. Petersburg State Pavlov Medical...

Completed

Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia

Opiate Dependence

Russian Federation
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone

Human Immunodeficiency Virus | Opiate Dependence

Russian Federation

3

Subscribe